1187856-49-0
1187856-49-0 structure
- Name: Ralinepag
- Chemical Name: Ralinepag
- CAS Number: 1187856-49-0
- Molecular Formula: C23H26ClNO5
- Molecular Weight: 431.909
- Catalog: Signaling Pathways GPCR/G Protein Prostaglandin Receptor
- Create Date: 2018-10-17 19:30:57
- Modify Date: 2024-01-19 06:50:03
-
Ralinepag is a potent, orally bioavailable and non-prostanoid prostacyclin (IP) receptor agonist, with EC50s of 8.5 nM, 530 nM and 850 nM for human and rat IP receptor and human DP1 receptor, respectively.
| Name | Ralinepag |
|---|---|
| Synonyms |
{[trans-4-({[(4-Chlorophenyl)(phenyl)carbamoyl]oxy}methyl)cyclohexyl]methoxy}acetic acid
10029 APD811 CQY12ZJN6E 2-[[trans-4-[[[(4-chlorophenyl)(phenyl)carbamoyl]oxy]methyl]cyclohexyl]methoxy]acetic acid MFCD28502072 Ralinepag Acetic acid, 2-[[trans-4-[[[[(4-chlorophenyl)phenylamino]carbonyl]oxy]methyl]cyclohexyl]methoxy]- UNII-CQY12ZJN6E |
| Description | Ralinepag is a potent, orally bioavailable and non-prostanoid prostacyclin (IP) receptor agonist, with EC50s of 8.5 nM, 530 nM and 850 nM for human and rat IP receptor and human DP1 receptor, respectively. |
|---|---|
| Related Catalog | |
| Target |
hIP:8.5 nM (EC50) rIP:530 nM (EC50) |
| In Vitro | Ralinepag is a potent non-prostanoid prostacyclin receptor agonist, with EC50s of 8.5 nM, 530 nM and 850 nM for human and rat IP receptor and human DP1 receptor, respectively. Ralinepag (5c) has potent receptor binding affinity at prostaglandin receptor, with Kis of 1.2 nM, 3 nM, 76 nM, and 256 nM for monkey, human, rat, and dog IP receptor (ligand, [3H]-iloprost), and 2.6 μM, 9.6 μM, 610 nM, 143 nM, and 678 nM for human DP1, EP1, EP2, EP3v6 and EP4 receptors (ligand, [3H]-PGE2), respectively. Moreover, Ralinepag shows no effect on cytochrome P450 enzymes (IC50 > 50 μM for CYPs 1A2, 2D6, 3A4 2C8, 2C9, and 2C19) or hERG channel functional activity in a patch clamp assay (IC50 > 30 μM). Ralinepag also inhibits the ADP-induced human platelet aggregation, with an IC50 of 38 nM[1]. |
| In Vivo | Ralinepag (30 mg/kg, p.o.) markedly reduces the monocrotaline (MCT)-induced increase in pulmonary arterial pressure and pulmonary vessel wall thickness in rats[1]. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 609.1±35.0 °C at 760 mmHg |
| Molecular Formula | C23H26ClNO5 |
| Molecular Weight | 431.909 |
| Flash Point | 322.2±25.9 °C |
| Exact Mass | 431.149963 |
| LogP | 4.86 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.582 |
| Storage condition | -20℃ |